Znanstveni rad - Pregledni rad
Current trends in the pharmacotherapy for obesity
Endocrine Oncology and Metabolism, 2 (2016), 1; 50-59. https://doi.org/10.21040/eom/2016.2.6


Citirajte ovaj rad

Klobučar Majanović, S., Crnčević Orlić, Ž. i Štimac, D. (2016). Current trends in the pharmacotherapy for obesity. Endocrine Oncology and Metabolism, 2. (1), 50-59. doi: 10.21040/eom/2016.2.6

Klobučar Majanović, Sanja, et al. "Current trends in the pharmacotherapy for obesity." Endocrine Oncology and Metabolism, vol. 2, br. 1, 2016, str. 50-59. https://doi.org/10.21040/eom/2016.2.6

Klobučar Majanović, Sanja, Željka Crnčević Orlić i Davor Štimac. "Current trends in the pharmacotherapy for obesity." Endocrine Oncology and Metabolism 2, br. 1 (2016): 50-59. https://doi.org/10.21040/eom/2016.2.6

Klobučar Majanović, S., Crnčević Orlić, Ž. i Štimac, D. (2016) 'Current trends in the pharmacotherapy for obesity', Endocrine Oncology and Metabolism, 2(1), str. 50-59. doi: 10.21040/eom/2016.2.6

Klobučar Majanović S, Crnčević Orlić Ž, Štimac D. Current trends in the pharmacotherapy for obesity. Endocrine Oncology and Metabolism [Internet]. 2016. [pristupljeno 21.05.2024.];2(1):50-59. doi: 10.21040/eom/2016.2.6

S. Klobučar Majanović, Ž. Crnčević Orlić i D. Štimac, "Current trends in the pharmacotherapy for obesity", Endocrine Oncology and Metabolism, vol. 2, br. 1, str. 50-59, 2016. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:359339. [Citirano: 21.05.2024.]